Logo: University of Southern California

Events Calendar


  • USC Physical Sciences in Oncology Center Monthly Seminar Series

    Fri, Sep 27, 2013 @ 11:45 AM - 01:00 PM

    Alfred E. Mann Department of Biomedical Engineering

    Conferences, Lectures, & Seminars


    Speaker: Christina Curtis, PhD, University of Southern California

    Talk Title: Leveraging integrative genomics and tumor evolutionary dynamics to infer mechanisms of disease progression

    Abstract: Although the direct observation of human tumor progression is impractical, the ancestral relationships between cancer cells are recorded in the form of mutations acquired during somatic cell division. As such, the dynamics of tumor growth can be inferred from genomic signatures found in the present day tumor. We have developed an experimental and computational framework that leverages these principles to delineate mechanisms of disease progression. For example, by employing a multiple sampling scheme and computational genomic inference framework in colorectal cancer, we find that tumors grow predominantly as a single expansion from the initial transformed cell into a large number of heterogeneous subclones in a Big Bang fashion. In this model, rapid expansion determines that most observable intra-tumor heterogeneity originates well before the neoplasm is detectable, irrespective of microenvironmental effects or subclone fitness changes. Hence, patterns of intra-tumor heterogeneity provide a looking glass into the primordial tumor, revealing early events that influence genomic and phenotypic outputs. In related work, we have demonstrated that it is possible to measure clinically relevant patient-specific parameters, including the cancer stem cell fraction, (a) symmetric cell division rate, mutation rate, and tumor age from genomic data. We are applying these approaches to clinically annotated colorectal cancer cohorts in order to discriminate between alternate models of metastatic dissemination. Similarly, we are developing tools to model therapeutic resistance to anti-HER2 agents in breast cancer. Our findings suggest that a quantitative understanding of tumor evolutionary dynamics will have significant implications for cancer diagnosis and prognosis, and ultimately for preventing resistance.


    Biography: USC was selected to establish a $16 million cancer research center as part of a new strategy against the disease by the U.S. National Institutes of Health and its National Cancer Institute. The new center is one of 12 in the nation to receive the designation. During the five-year initiative, the Physical Sciences-Oncology Centers will take new, nontraditional approaches to cancer research by studying the physical laws and principles of cancer; evolution and the evolutionary theory of cancer; information coding, decoding, transfer and translation in cancer; and ways to de-convolute cancer's complexity. As part of the outreach component of this grant, the Center for Applied Molecular Medicine is hosting a monthly seminar series

    Host: USC PSOC

    More Information: USC-PSOC_MonthlySeminar.pdf

    Location: Clinical Science Center (CSC) - Harkness Auditorium #240

    Audiences: Everyone Is Invited

    Contact: Kristina Gerber

    Add to Google CalendarDownload ICS File for OutlookDownload iCal File

Return to Calendar